Impax Asset Management Group
TECH icon

Impax Asset Management Group’s Bio-Techne TECH Stock Holding History

Impax Asset Management Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Hold
195,000
– – 0.09% 149
2026
Q1 		$10.2M Hold
195,000
– – 0.07% 153
2025
Q4 		$11.5M Buy
+195,000
New +$11.8M 0.07% 140

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Impax Asset Management Group's TECH Position: Q2 2026 in Review

Impax Asset Management Group held its Bio-Techne (TECH) position steady in Q2 2026 at 195,000 shares worth $13.8M. The position accounts for 0.09% of the portfolio, ranked #149.

Impax Asset Management Group first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Impax Asset Management Group held 195,000 shares of Bio-Techne worth $13.8M as of Q2 2026.
  • Impax Asset Management Group left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up 0.09% of Impax Asset Management Group's portfolio in Q2 2026, its #149 holding.
  • Impax Asset Management Group first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.